328 related articles for article (PubMed ID: 24047967)
1. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
2. Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.
Nyström J; Stenkvist J; Häggblom A; Weiland O; Nowak P
PLoS One; 2015; 10(3):e0118643. PubMed ID: 25785448
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
4. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
Negi N; Singh R; Sharma A; Das BK; Vajpayee M
Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
[TBL] [Abstract][Full Text] [Related]
7. Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.
Pilakka-Kanthikeel S; Kris A; Selvaraj A; Swaminathan S; Pahwa S
J Acquir Immune Defic Syndr; 2014 May; 66(1):16-24. PubMed ID: 24378729
[TBL] [Abstract][Full Text] [Related]
8. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
[TBL] [Abstract][Full Text] [Related]
9. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
[TBL] [Abstract][Full Text] [Related]
10. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
Vesterbacka J; Barqasho B; Häggblom A; Nowak P
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
[TBL] [Abstract][Full Text] [Related]
11. Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.
Pilakka-Kanthikeel S; Huang S; Fenton T; Borkowsky W; Cunningham CK; Pahwa S
Pediatr Infect Dis J; 2012 Jun; 31(6):583-91. PubMed ID: 22333700
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
Medicine (Baltimore); 2015 May; 94(17):e781. PubMed ID: 25929922
[TBL] [Abstract][Full Text] [Related]
13. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L
PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854
[TBL] [Abstract][Full Text] [Related]
14. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
Front Immunol; 2019; 10():2185. PubMed ID: 31572392
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
Jiang W; Lederman MM; Hunt P; Sieg SF; Haley K; Rodriguez B; Landay A; Martin J; Sinclair E; Asher AI; Deeks SG; Douek DC; Brenchley JM
J Infect Dis; 2009 Apr; 199(8):1177-85. PubMed ID: 19265479
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
[TBL] [Abstract][Full Text] [Related]
17. Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.
Monnig MA; Kahler CW; Cioe PA; Tucker L; Monti PM; Mayer KH; Ramratnam B
AIDS Care; 2016 Nov; 28(11):1434-40. PubMed ID: 27242060
[TBL] [Abstract][Full Text] [Related]
18. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
19. Low-level HIV viremia is associated with microbial translocation and inflammation.
Reus S; Portilla J; Sánchez-Payá J; Giner L; Francés R; Such J; Boix V; Merino E; Gimeno A
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):129-34. PubMed ID: 23018379
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]